---
title: "Alphatec | 10-Q: FY2025 Q2 Revenue Beats Estimate at USD 185.54 M"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/251063677.md"
datetime: "2025-07-31T20:53:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251063677.md)
  - [en](https://longbridge.com/en/news/251063677.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251063677.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/251063677.md) | [English](https://longbridge.com/en/news/251063677.md)


# Alphatec | 10-Q: FY2025 Q2 Revenue Beats Estimate at USD 185.54 M

Revenue: As of FY2025 Q2, the actual value is USD 185.54 M, beating the estimate of USD 178.85 M.

EPS: As of FY2025 Q2, the actual value is USD -0.27, missing the estimate of USD -0.1883.

### Segment Revenue

-   Revenue from products and services for the three months ended June 30, 2025, was $185.5 million, an increase of 27% compared to $145.6 million for the same period in 2024. For the six months ended June 30, 2025, revenue was $354.7 million, an increase of 25% compared to $284.1 million for the same period in 2024.

### Operational Metrics

-   **Gross Profit**: For the three months ended June 30, 2025, gross profit was $129.1 million, compared to $102.6 million for the same period in 2024. For the six months ended June 30, 2025, gross profit was $245.1 million, compared to $199.9 million for the same period in 2024.
-   **Operating Loss**: Operating loss for the three months ended June 30, 2025, was -$13.1 million, compared to -$35.3 million for the same period in 2024. For the six months ended June 30, 2025, operating loss was -$57.4 million, compared to -$78.6 million for the same period in 2024.
-   **Net Loss**: Net loss for the three months ended June 30, 2025, was -$41.1 million, compared to -$40.7 million for the same period in 2024. For the six months ended June 30, 2025, net loss was -$93.1 million, compared to -$89.2 million for the same period in 2024.

### Cash Flow

-   **Operating Cash Flow**: Net cash provided by operating activities for the six months ended June 30, 2025, was $10.5 million, compared to net cash used in operating activities of -$49.8 million for the same period in 2024.
-   **Investing Cash Flow**: Net cash used in investing activities for the six months ended June 30, 2025, was -$23.8 million, compared to -$69.5 million for the same period in 2024.
-   **Financing Cash Flow**: Net cash provided by financing activities for the six months ended June 30, 2025, was $31.1 million, compared to net cash used in financing activities of -$1.1 million for the same period in 2024.

### Unique Metrics

-   **Interest Expense**: Interest expense, net, for the three months ended June 30, 2025, was -$12.3 million, compared to -$5.8 million for the same period in 2024. For the six months ended June 30, 2025, interest expense, net, was -$20.2 million, compared to -$11.2 million for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: Alphatec Holdings, Inc. aims to continue expanding its surgeon user base and product portfolio, focusing on increasing adoption of its technology to drive revenue growth.
-   **Non-Core Business**: The company plans to use the remainder of the net proceeds from the 2030 Notes for general corporate purposes, following the repurchase of 80% of its 2026 convertible notes.

### 相關股票

- [Alphatec (ATEC.US)](https://longbridge.com/zh-HK/quote/ATEC.US.md)

## 相關資訊與研究

- [Alphatec Holdings Officer Sells Shares](https://longbridge.com/zh-HK/news/278436292.md)
- [Alphatec Holdings Grants 67,643 RSUs to New Employees as Inducement Awards](https://longbridge.com/zh-HK/news/272282884.md)
- [Alphatec Holdings CEO Patrick Miles Reports Sale of Common Shares](https://longbridge.com/zh-HK/news/271711743.md)
- [Alphatec Holdings CEO Sells 100,000 Shares](https://longbridge.com/zh-HK/news/271712882.md)
- [Alphatec Holdings Secures Exclusive U.S. Rights to Theradaptive's OsteoAdapt Platform](https://longbridge.com/zh-HK/news/272285784.md)